BioLife Solutions Inc
BLFS24.900USD
-0.510-2.01%
收盤 12/26, 16:00（美東）報價延遲15分鐘
1.19B總市值
虧損本益比TTM
關於 BioLife Solutions Inc 公司
BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
BioLife Solutions Inc簡介
公司代碼BLFS
公司名稱BioLife Solutions Inc
上市日期Nov 22, 1989
CEODe Greef (Roderick)
員工數量159
證券類型Ordinary Share
年結日Nov 22
公司地址Suite 310
城市BOTHELL
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編98021
電話14254011400
網址https://www.biolifesolutions.com/
公司代碼BLFS
上市日期Nov 22, 1989
CEODe Greef (Roderick)
BioLife Solutions Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
252.89K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.11K
-0.28%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
68.75K
-30.38%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
49.99K
-0.43%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
38.11K
-7.30%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
25.93K
-0.42%
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
13.81K
-42.00%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
252.89K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.11K
-0.28%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
68.75K
-30.38%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
49.99K
-0.43%
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
由於公司未披露，未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
股東統計
更新時間: 11月15日 週六
更新時間: 11月15日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.60%
T. Rowe Price Investment Management, Inc.
8.45%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.15%
其他
55.21%
持股股東
持股股東
佔比
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.60%
T. Rowe Price Investment Management, Inc.
8.45%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.15%
其他
55.21%
股東類型
持股股東
佔比
Investment Advisor
49.20%
Investment Advisor/Hedge Fund
34.12%
Hedge Fund
15.54%
Research Firm
2.32%
Individual Investor
2.00%
Pension Fund
1.60%
Bank and Trust
0.65%
Sovereign Wealth Fund
0.08%
Insurance Company
0.03%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
402
49.86M
109.33%
-743.44K
2025Q3
418
50.60M
112.73%
+431.43K
2025Q2
417
51.14M
109.98%
+2.32M
2025Q1
412
48.78M
108.79%
-2.89M
2024Q4
397
47.68M
109.40%
+879.99K
2024Q3
391
46.15M
113.67%
-1.38M
2024Q2
371
47.55M
108.21%
+1.88M
2024Q1
363
45.48M
113.98%
-6.15M
2023Q4
383
46.46M
115.88%
+36.24K
2023Q3
386
44.68M
106.82%
+2.82M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Casdin Capital, LLC
6.71M
14%
-1.00M
-12.97%
Aug 15, 2025
BlackRock Institutional Trust Company, N.A.
5.08M
10.61%
+12.43K
+0.25%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
4.25M
8.86%
+2.90M
+215.04%
Jun 30, 2025
Invesco Advisers, Inc.
3.46M
7.22%
+126.62K
+3.80%
Jun 30, 2025
The Vanguard Group, Inc.
2.89M
6.03%
+93.13K
+3.33%
Jun 30, 2025
State Street Investment Management (US)
1.41M
2.94%
-24.84K
-1.73%
Jun 30, 2025
Fred Alger Management, LLC
1.25M
2.61%
-285.09K
-18.60%
Jun 30, 2025
MFS Investment Management
1.10M
2.3%
+337.42K
+44.13%
Jun 30, 2025
Rockefeller Capital Management
1.03M
2.14%
+62.16K
+6.45%
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Invesco S&P SmallCap Health Care ETF
0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
0.52%
Zacks Small/Mid Cap ETF
0.41%
iShares Micro-Cap ETF
0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
0.15%
First Trust Small Cap Growth AlphaDEX Fund
0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.14%
iShares S&P Small-Cap 600 Growth ETF
0.14%
iShares ESG Select Screened S&P Small-Cap ETF
0.09%
查看更多
Invesco S&P SmallCap Health Care ETF
佔比0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
佔比0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
佔比0.52%
Zacks Small/Mid Cap ETF
佔比0.41%
iShares Micro-Cap ETF
佔比0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
佔比0.15%
First Trust Small Cap Growth AlphaDEX Fund
佔比0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
佔比0.14%
iShares S&P Small-Cap 600 Growth ETF
佔比0.14%
iShares ESG Select Screened S&P Small-Cap ETF
佔比0.09%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
BioLife Solutions Inc的前五大股東是誰？
BioLife Solutions Inc的前五大股東如下：
Casdin Capital, LLC持有股份：6.71M佔總股份比例：14.00%。
BlackRock Institutional Trust Company, N.A.持有股份：5.08M佔總股份比例：10.61%。
T. Rowe Price Investment Management, Inc.持有股份：4.25M佔總股份比例：8.86%。
Invesco Advisers, Inc.持有股份：3.46M佔總股份比例：7.22%。
The Vanguard Group, Inc.持有股份：2.89M佔總股份比例：6.03%。
Casdin Capital, LLC持有股份：6.71M佔總股份比例：14.00%。
BlackRock Institutional Trust Company, N.A.持有股份：5.08M佔總股份比例：10.61%。
T. Rowe Price Investment Management, Inc.持有股份：4.25M佔總股份比例：8.86%。
Invesco Advisers, Inc.持有股份：3.46M佔總股份比例：7.22%。
The Vanguard Group, Inc.持有股份：2.89M佔總股份比例：6.03%。
BioLife Solutions Inc的前三大股東類型是什麼？
BioLife Solutions Inc 的前三大股東類型分別是：
Casdin Capital, LLC
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
Casdin Capital, LLC
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
有多少機構持有BioLife Solutions Inc(BLFS)的股份？
截至2025Q4，共有402家機構持有BioLife Solutions Inc的股份，合計持有的股份價值約為49.86M，占公司總股份的109.33% 。與2025Q3相比，機構持股有所增加，增幅為-3.40%。
哪個業務部門對BioLife Solutions Inc的收入貢獻最大？
在FY2025Q2，Product Revenue-Cell processing業務部門對BioLife Solutions Inc的收入貢獻最大，創收22.90M，占總收入的90.08% 。
